State of Alaska Department of Revenue’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-43,596
Closed -$174K 1638
2019
Q4
$174K Sell
43,596
-280
-0.6% -$1.31K ﹤0.01% 1574
2019
Q3
$214K Buy
43,876
+24,547
+127% +$137K ﹤0.01% 1533
2019
Q2
$117K Buy
19,329
+240
+1% +$1.28K ﹤0.01% 1565
2019
Q1
$110K Buy
19,089
+215
+1% +$2.22K ﹤0.01% 1585
2018
Q4
$254K Buy
18,874
+60
+0.3% +$1.01K ﹤0.01% 1317
2018
Q3
$365K Buy
18,814
+3,061
+19% +$65.2K 0.01% 1276
2018
Q2
$402K Buy
15,753
+260
+2% +$6.06K 0.01% 1204
2018
Q1
$312K Buy
15,493
+5,950
+62% +$139K 0.01% 1219
2017
Q4
$191K Buy
9,543
+100
+1% +$1.97K ﹤0.01% 1302
2017
Q3
$195K Buy
9,443
+820
+10% +$13.9K 0.01% 1021
2017
Q2
$127K Buy
8,623
+3,833
+80% +$63.9K 0.01% 1038
2017
Q1
$76K Buy
4,790
+120
+3% +$1.73K 0.01% 1028
2016
Q4
$58K Buy
+4,670
New +$87K 0.01% 803

Other funds holding DPLO

State of Alaska Department of Revenue's DPLO Position: Q1 2020 in Review

State of Alaska Department of Revenue sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 43,596 shares — an estimated $174K sold.

State of Alaska Department of Revenue first reported a position in DPLO in Q4 2016 and held it in 13 quarters. The position peaked at $402K in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • State of Alaska Department of Revenue reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 43,596 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $174K.
  • State of Alaska Department of Revenue first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 13 quarters.
  • State of Alaska Department of Revenue's DIPLOMAT PHARMACY, INC. position peaked at $402K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on State of Alaska Department of Revenue's 13F filing for Q1 2020, filed 6 Apr 2020.